Earnings Call · Q1 FY2022·2022-05-16

Q1 22EPS -19.09%·Rev n/aQ4 21EPS -5.60%·Rev n/aQ3 21EPS -23.85%·Rev n/aQ2 21EPS -26.74%·Rev n/a⚠ consensus missing

Taysha Gene Therapies, Inc. TSHA

Kimberly Lee — Host/Moderator

Suyash Prasad — Chief Medical Officer and Head of R&D

Kamran Alam — Chief Financial Officer

−3.5%1d on move date−3.1% vs SPY3d−11.9%5d−19.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more TSHA calls or request research access.

More TSHA calls Browse calls Request research access